ONTOLOGY REPORT - ANNOTATIONS
| Term: | phorbol 13-acetate 12-myristate |
|
| Accession: | CHEBI:37537
|
browse the term
|
| Definition: | A phorbol ester that has formula C36H56O8. |
| Synonyms: | exact_synonym: | (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl tetradecanoate |
| | related_synonym: | 12-O-Tetradecanoylphorbol 13-acetate; 12-Tetradecanoylphorbol 13-acetate; C36H56O8; InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1; InChIKey=PHEDXBVPIONUQT-RGYGYFBISA-N; PMA; [H][C@@]12C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@]3([H])[C@@]1(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@]1(OC(C)=O)[C@@]2([H])C1(C)C; phorbol 12-tetradecanoate 13-acetate; tetradecanoylphorbol acetate |
| | alt_id: | CHEBI:745; CHEBI:746 |
| | xref_casrn: | 16561-29-8 |
| | xref: | ChEMBL:228763 "ChEMBL COMPOUND"; ChemIDplus:16561-29-8 "CAS Registry Number"; ChemIDplus:2407201 "Beilstein Registry Number"; KEGG COMPOUND:16561-29-8 "CAS Registry Number"; KEGG COMPOUND:C05151 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D013755 |
|
|
phorbol 13-acetate 12-myristate
|
| G |
ABCB4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
multiple interactions |
EXP |
7 |
87,031,361 |
87,105,019 |
RGD:6480464 |
CTD |
| G |
ABCB4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
decreases expression |
EXP |
7 |
87,031,361 |
87,105,019 |
RGD:6480464 |
CTD |
| G |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
decreases expression |
EXP |
16 |
16,043,434 |
16,236,931 |
RGD:6480464 |
CTD |
| G |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
16,043,434 |
16,236,931 |
RGD:6480464 |
CTD |
| G |
ABCC2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
10 |
101,542,463 |
101,611,662 |
RGD:6480464 |
CTD |
| G |
ABCC4 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
decreases expression |
EXP |
13 |
95,672,083 |
95,953,687 |
RGD:6480464 |
CTD |
| G |
ADAM12 |
ADAM metallopeptidase domain 12 |
|
multiple interactions |
EXP |
10 |
127,702,898 |
128,077,127 |
RGD:6480464 |
CTD |
| G |
ADAM17 |
ADAM metallopeptidase domain 17 |
|
increases response to substance |
ISO |
2 |
9,629,392 |
9,695,917 |
RGD:6480464 |
CTD |
| G |
ADAM8 |
ADAM metallopeptidase domain 8 |
|
multiple interactions |
EXP |
10 |
135,075,920 |
135,090,407 |
RGD:6480464 |
CTD |
| G |
ADM |
adrenomedullin |
|
decreases expression |
ISO |
11 |
10,326,642 |
10,328,923 |
RGD:6480464 |
CTD |
| G |
ADRB2 |
adrenoceptor beta 2, surface |
|
increases phosphorylation |
EXP |
5 |
148,206,156 |
148,208,197 |
RGD:6480464 |
CTD |
| G |
AFP |
alpha-fetoprotein |
|
multiple interactions |
ISO |
4 |
74,301,933 |
74,321,492 |
RGD:6480464 |
CTD |
| G |
AHRR |
aryl-hydrocarbon receptor repressor |
|
multiple interactions |
ISO |
5 |
304,291 |
438,406 |
RGD:6480464 |
CTD |
| G |
AHRR |
aryl-hydrocarbon receptor repressor |
|
increases expression |
ISO |
5 |
304,291 |
438,406 |
RGD:6480464 |
CTD |
| G |
ANXA10 |
annexin A10 |
|
multiple interactions |
EXP |
4 |
169,013,688 |
169,108,893 |
RGD:6480464 |
CTD |
| G |
ANXA3 |
annexin A3 |
|
multiple interactions |
EXP |
4 |
79,472,742 |
79,531,605 |
RGD:6480464 |
CTD |
| G |
APAF1 |
apoptotic peptidase activating factor 1 |
|
affects expression |
EXP |
12 |
99,039,078 |
99,129,211 |
RGD:6480464 |
CTD |
| G |
APEX2 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
increases expression |
EXP |
X |
55,026,780 |
55,034,212 |
RGD:6480464 |
CTD |
| G |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
|
multiple interactions |
EXP |
11 |
129,939,716 |
130,014,706 |
RGD:6480464 |
CTD |
| G |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
|
increases secretion |
EXP |
11 |
129,939,716 |
130,014,706 |
RGD:6480464 |
CTD |
| G |
ARF1 |
ADP-ribosylation factor 1 |
|
affects localization |
EXP |
1 |
228,270,361 |
228,286,913 |
RGD:6480464 |
CTD |
| G |
ARF6 |
ADP-ribosylation factor 6 |
|
affects localization |
EXP |
14 |
50,359,736 |
50,363,772 |
RGD:6480464 |
CTD |
| G |
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
|
multiple interactions |
EXP |
X |
62,854,848 |
63,005,426 |
RGD:6480464 |
CTD |
| G |
ARL4C |
ADP-ribosylation factor-like 4C |
|
multiple interactions |
EXP |
2 |
235,401,685 |
235,405,693 |
RGD:6480464 |
CTD |
| G |
ARL6IP5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
multiple interactions |
EXP |
3 |
69,134,090 |
69,155,239 |
RGD:6480464 |
CTD |
| G |
ARL6IP5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases expression |
EXP |
3 |
69,134,090 |
69,155,239 |
RGD:6480464 |
CTD |
| G |
ASS1 |
argininosuccinate synthase 1 |
|
multiple interactions |
EXP |
9 |
133,320,094 |
133,376,661 |
RGD:6480464 |
CTD |
| G |
ATF5 |
activating transcription factor 5 |
|
multiple interactions |
EXP |
19 |
50,431,959 |
50,437,193 |
RGD:6480464 |
CTD |
| G |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
increases expression |
ISO |
1 |
169,075,947 |
169,101,960 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
increases activity |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
AURKA |
aurora kinase A |
|
increases expression |
EXP |
20 |
54,944,445 |
54,967,351 |
RGD:6480464 |
CTD |
| G |
BAK1 |
BCL2-antagonist/killer 1 |
|
increases expression |
EXP |
6 |
33,540,323 |
33,548,070 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2A1 |
BCL2-related protein A1 |
|
multiple interactions |
EXP |
15 |
80,253,232 |
80,263,643 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
increases expression |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BHMT |
betaine--homocysteine S-methyltransferase |
|
multiple interactions |
ISO |
5 |
78,407,604 |
78,428,113 |
RGD:6480464 |
CTD |
| G |
BIRC2 |
baculoviral IAP repeat containing 2 |
|
affects localization |
EXP |
11 |
102,217,913 |
102,249,401 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
multiple interactions |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
increases expression |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
increases expression |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BNIP3L |
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
multiple interactions |
ISO |
8 |
26,240,523 |
26,270,644 |
RGD:6480464 |
CTD |
| G |
BNIP3L |
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
increases expression |
ISO |
8 |
26,240,523 |
26,270,644 |
RGD:6480464 |
CTD |
| G |
BRCA1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
17 |
41,196,312 |
41,277,500 |
RGD:6480464 |
CTD |
| G |
BSG |
basigin (Ok blood group) |
|
multiple interactions |
EXP |
19 |
571,277 |
583,493 |
RGD:6480464 |
CTD |
| G |
BSG |
basigin (Ok blood group) |
|
increases expression |
EXP |
19 |
571,277 |
583,493 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
multiple interactions |
EXP |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
increases expression |
EXP |
15 |
40,453,210 |
40,513,337 |
RGD:6480464 |
CTD |
| G |
CA14 |
carbonic anhydrase XIV |
|
multiple interactions |
EXP |
1 |
150,230,218 |
150,237,478 |
RGD:6480464 |
CTD |
| G |
CALR |
calreticulin |
|
decreases expression |
EXP |
19 |
13,049,414 |
13,055,304 |
RGD:6480464 |
CTD |
| G |
CAPN11 |
calpain 11 |
|
multiple interactions |
EXP |
6 |
44,126,548 |
44,152,139 |
RGD:6480464 |
CTD |
| G |
CAPN9 |
calpain 9 |
|
multiple interactions |
EXP |
1 |
230,883,130 |
230,937,749 |
RGD:6480464 |
CTD |
| G |
CASP12 |
caspase 12 (gene/pseudogene) |
|
multiple interactions |
EXP |
11 |
104,756,445 |
104,769,397 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
decreases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CCL1 |
chemokine (C-C motif) ligand 1 |
|
multiple interactions |
EXP |
17 |
32,687,399 |
32,690,252 |
RGD:6480464 |
CTD |
| G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
EXP |
17 |
32,612,687 |
32,615,199 |
RGD:6480464 |
CTD |
| G |
CCL18 |
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
|
multiple interactions |
EXP |
17 |
34,391,643 |
34,398,841 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases secretion |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCL4 |
chemokine (C-C motif) ligand 4 |
|
multiple interactions |
EXP |
17 |
34,431,220 |
34,433,014 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
multiple interactions |
EXP |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
decreases expression |
EXP |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
increases expression |
EXP |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
increases expression |
EXP |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
increases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
multiple interactions |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB2 |
cyclin B2 |
|
increases expression |
EXP |
15 |
59,397,284 |
59,417,244 |
RGD:6480464 |
CTD |
| G |
CCNB2 |
cyclin B2 |
|
multiple interactions |
EXP |
15 |
59,397,284 |
59,417,244 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND3 |
cyclin D3 |
|
increases expression |
EXP |
6 |
41,902,671 |
42,016,610 |
RGD:6480464 |
CTD |
| G |
CCND3 |
cyclin D3 |
|
multiple interactions |
EXP |
6 |
41,902,671 |
42,016,610 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
multiple interactions |
EXP |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
increases expression |
EXP |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CD14 |
CD14 molecule |
|
increases expression |
EXP |
5 |
140,011,313 |
140,013,286 |
RGD:6480464 |
CTD |
| G |
CD28 |
CD28 molecule |
|
multiple interactions |
EXP |
2 |
204,571,198 |
204,603,635 |
RGD:6480464 |
CTD |
| G |
CD28 |
CD28 molecule |
|
increases expression |
EXP |
2 |
204,571,198 |
204,603,635 |
RGD:6480464 |
CTD |
| G |
CD34 |
CD34 molecule |
|
multiple interactions |
EXP |
1 |
208,059,883 |
208,084,683 |
RGD:6480464 |
CTD |
| G |
CD34 |
CD34 molecule |
|
increases expression |
EXP |
1 |
208,059,883 |
208,084,683 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD4 |
CD4 molecule |
|
multiple interactions |
EXP |
12 |
6,898,638 |
6,929,976 |
RGD:6480464 |
CTD |
| G |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
EXP |
20 |
44,746,906 |
44,758,384 |
RGD:6480464 |
CTD |
| G |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
EXP |
20 |
44,746,906 |
44,758,384 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
increases expression |
EXP |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CD58 |
CD58 molecule |
|
multiple interactions |
EXP |
1 |
117,057,156 |
117,113,715 |
RGD:6480464 |
CTD |
| G |
CD69 |
CD69 molecule |
|
increases expression |
EXP |
12 |
9,905,082 |
9,913,497 |
RGD:6480464 |
CTD |
| G |
CD9 |
CD9 molecule |
|
increases expression |
EXP |
12 |
6,309,482 |
6,347,437 |
RGD:6480464 |
CTD |
| G |
CD9 |
CD9 molecule |
|
multiple interactions |
EXP |
12 |
6,309,482 |
6,347,437 |
RGD:6480464 |
CTD |
| G |
CDC20 |
cell division cycle 20 |
|
multiple interactions |
EXP |
1 |
43,824,626 |
43,828,874 |
RGD:6480464 |
CTD |
| G |
CDC20 |
cell division cycle 20 |
|
increases expression |
EXP |
1 |
43,824,626 |
43,828,874 |
RGD:6480464 |
CTD |
| G |
CDC25B |
cell division cycle 25B |
|
increases expression |
EXP |
20 |
3,776,401 |
3,786,762 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
increases activity |
EXP |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases phosphorylation |
EXP |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
multiple interactions |
EXP |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases expression |
EXP |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
decreases expression |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
multiple interactions |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
|
multiple interactions |
EXP |
11 |
2,904,448 |
2,906,995 |
RGD:6480464 |
CTD |
| G |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
EXP |
9 |
21,967,751 |
21,994,490 |
RGD:6480464 |
CTD |
| G |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
9 |
21,967,751 |
21,994,490 |
RGD:6480464 |
CTD |
| G |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
EXP |
9 |
22,002,902 |
22,009,312 |
RGD:6480464 |
CTD |
| G |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
multiple interactions |
EXP |
1 |
51,434,367 |
51,440,309 |
RGD:6480464 |
CTD |
| G |
CHUK |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
EXP |
10 |
101,948,124 |
101,989,344 |
RGD:6480464 |
CTD |
| G |
CHUK |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
10 |
101,948,124 |
101,989,344 |
RGD:6480464 |
CTD |
| G |
CHUK |
conserved helix-loop-helix ubiquitous kinase |
|
increases activity |
EXP |
10 |
101,948,124 |
101,989,344 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREBBP |
CREB binding protein |
|
multiple interactions |
ISO |
16 |
3,775,055 |
3,930,121 |
RGD:6480464 |
CTD |
| G |
CRTAM |
cytotoxic and regulatory T cell molecule |
|
multiple interactions |
EXP |
11 |
122,709,255 |
122,743,347 |
RGD:6480464 |
CTD |
| G |
CRY1 |
cryptochrome 1 (photolyase-like) |
|
increases expression |
EXP |
12 |
107,385,142 |
107,487,635 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
17 |
38,171,614 |
38,174,066 |
RGD:6480464 |
CTD |
| G |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
EXP |
4 |
74,861,359 |
74,864,416 |
RGD:6480464 |
CTD |
| G |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
|
multiple interactions |
EXP |
4 |
74,702,273 |
74,704,477 |
RGD:6480464 |
CTD |
| G |
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
|
multiple interactions |
EXP |
2 |
219,027,568 |
219,031,716 |
RGD:6480464 |
CTD |
| G |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
|
multiple interactions |
EXP |
2 |
218,990,013 |
219,001,976 |
RGD:6480464 |
CTD |
| G |
CYBB |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
EXP |
X |
37,639,270 |
37,672,714 |
RGD:6480464 |
CTD |
| G |
CYBB |
cytochrome b-245, beta polypeptide |
|
increases expression |
EXP |
X |
37,639,270 |
37,672,714 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
EXP |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYP11B2 |
cytochrome P450, family 11, subfamily B, polypeptide 2 |
|
decreases expression |
EXP |
8 |
143,991,975 |
143,999,259 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
decreases activity |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
affects response to substance |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions |
EXP |
2 |
38,294,746 |
38,303,323 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases expression |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2F1 |
cytochrome P450, family 2, subfamily F, polypeptide 1 |
|
multiple interactions |
ISO |
19 |
41,620,353 |
41,634,281 |
RGD:6480464 |
CTD |
| G |
CYP7A1 |
cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
59,402,737 |
59,412,720 |
RGD:6480464 |
CTD |
| G |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
65,508,529 |
65,711,348 |
RGD:6480464 |
CTD |
| G |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
decreases activity |
ISO |
8 |
65,508,529 |
65,711,348 |
RGD:6480464 |
CTD |
| G |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
decreases expression |
ISO |
8 |
65,508,529 |
65,711,348 |
RGD:6480464 |
CTD |
| G |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
|
multiple interactions |
ISO |
1 |
86,046,444 |
86,049,650 |
RGD:6480464 |
CTD |
| G |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
1 |
86,046,444 |
86,049,650 |
RGD:6480464 |
CTD |
| G |
DCT |
dopachrome tautomerase |
|
decreases expression |
EXP |
13 |
95,091,835 |
95,131,936 |
RGD:6480464 |
CTD |
| G |
DCT |
dopachrome tautomerase |
|
multiple interactions |
EXP |
13 |
95,091,835 |
95,131,936 |
RGD:6480464 |
CTD |
| G |
DIO3 |
deiodinase, iodothyronine, type III |
|
increases activity |
EXP |
14 |
102,027,688 |
102,029,789 |
RGD:6480464 |
CTD |
| G |
DIO3 |
deiodinase, iodothyronine, type III |
|
multiple interactions |
ISO |
14 |
102,027,688 |
102,029,789 |
RGD:6480464 |
CTD |
| G |
DIO3 |
deiodinase, iodothyronine, type III |
|
increases activity |
ISO |
14 |
102,027,688 |
102,029,789 |
RGD:6480464 |
CTD |
| G |
DLK1 |
delta-like 1 homolog (Drosophila) |
|
affects response to substance |
EXP |
14 |
101,193,202 |
101,201,467 |
RGD:6480464 |
CTD |
| G |
DNAJC3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions |
ISO |
13 |
96,329,393 |
96,447,243 |
RGD:6480464 |
CTD |
| G |
DPYD |
dihydropyrimidine dehydrogenase |
|
multiple interactions |
EXP |
1 |
97,543,299 |
98,386,615 |
RGD:6480464 |
CTD |
| G |
DUSP13 |
dual specificity phosphatase 13 |
|
increases expression |
EXP |
10 |
76,854,190 |
76,868,970 |
RGD:6480464 |
CTD |
| G |
E2F4 |
E2F transcription factor 4, p107/p130-binding |
|
multiple interactions |
EXP |
16 |
67,226,068 |
67,232,821 |
RGD:6480464 |
CTD |
| G |
E2F4 |
E2F transcription factor 4, p107/p130-binding |
|
increases expression |
EXP |
16 |
67,226,068 |
67,232,821 |
RGD:6480464 |
CTD |
| G |
EFNA4 |
ephrin-A4 |
|
multiple interactions |
EXP |
1 |
155,036,213 |
155,042,029 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
EXP |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
EXP |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
EXP |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR3 |
early growth response 3 |
|
multiple interactions |
ISO |
8 |
22,545,174 |
22,550,815 |
RGD:6480464 |
CTD |
| G |
EGR4 |
early growth response 4 |
|
multiple interactions |
EXP |
2 |
73,518,057 |
73,520,829 |
RGD:6480464 |
CTD |
| G |
EIF1 |
eukaryotic translation initiation factor 1 |
|
multiple interactions |
ISO |
17 |
39,845,127 |
39,847,898 |
RGD:6480464 |
CTD |
| G |
EIF4G2 |
eukaryotic translation initiation factor 4 gamma, 2 |
|
increases expression |
EXP |
11 |
10,818,593 |
10,830,582 |
RGD:6480464 |
CTD |
| G |
EIF5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
EXP |
14 |
103,800,339 |
103,811,362 |
RGD:6480464 |
CTD |
| G |
ENDOG |
endonuclease G |
|
multiple interactions |
EXP |
9 |
131,580,779 |
131,584,955 |
RGD:6480464 |
CTD |
| G |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
multiple interactions |
EXP |
17 |
37,844,393 |
37,884,915 |
RGD:6480464 |
CTD |
| G |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
increases expression |
EXP |
17 |
37,844,393 |
37,884,915 |
RGD:6480464 |
CTD |
| G |
EREG |
epiregulin |
|
multiple interactions |
ISO |
4 |
75,230,860 |
75,254,477 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
increases expression |
EXP |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
EXP |
14 |
64,693,751 |
64,805,268 |
RGD:6480464 |
CTD |
| G |
ESR2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
EXP |
14 |
64,693,751 |
64,805,268 |
RGD:6480464 |
CTD |
| G |
ESR2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
EXP |
14 |
64,693,751 |
64,805,268 |
RGD:6480464 |
CTD |
| G |
ESR2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
EXP |
14 |
64,693,751 |
64,805,268 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FEN1 |
flap structure-specific endonuclease 1 |
|
increases expression |
EXP |
11 |
61,560,109 |
61,564,716 |
RGD:6480464 |
CTD |
| G |
FGF16 |
fibroblast growth factor 16 |
|
multiple interactions |
EXP |
X |
76,709,645 |
76,712,013 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
multiple interactions |
ISO |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
increases secretion |
EXP |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
multiple interactions |
ISO |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FGFR2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
10 |
123,237,844 |
123,357,972 |
RGD:6480464 |
CTD |
| G |
FMO5 |
flavin containing monooxygenase 5 |
|
multiple interactions |
EXP |
1 |
146,655,884 |
146,697,230 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
multiple interactions |
EXP |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
increases secretion |
EXP |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
multiple interactions |
EXP |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOSB |
FBJ murine osteosarcoma viral oncogene homolog B |
|
increases expression |
EXP |
19 |
45,971,253 |
45,978,437 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
multiple interactions |
EXP |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
increases expression |
ISO |
4 |
46,920,917 |
46,996,424 |
RGD:6480464 |
CTD |
| G |
GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
multiple interactions |
ISO |
4 |
46,920,917 |
46,996,424 |
RGD:6480464 |
CTD |
| G |
GATA1 |
GATA binding protein 1 (globin transcription factor 1) |
|
multiple interactions |
EXP |
X |
48,644,982 |
48,652,718 |
RGD:6480464 |
CTD |
| G |
GATA1 |
GATA binding protein 1 (globin transcription factor 1) |
|
increases activity |
EXP |
X |
48,644,982 |
48,652,718 |
RGD:6480464 |
CTD |
| G |
GATA2 |
GATA binding protein 2 |
|
increases expression |
EXP |
3 |
128,198,265 |
128,212,030 |
RGD:6480464 |
CTD |
| G |
GATA2 |
GATA binding protein 2 |
|
multiple interactions |
EXP |
3 |
128,198,265 |
128,212,030 |
RGD:6480464 |
CTD |
| G |
GATA4 |
GATA binding protein 4 |
|
increases phosphorylation |
ISO |
8 |
11,561,717 |
11,617,509 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GDF10 |
growth differentiation factor 10 |
|
multiple interactions |
EXP |
10 |
48,425,785 |
48,439,138 |
RGD:6480464 |
CTD |
| G |
GFI1 |
growth factor independent 1 transcription repressor |
|
decreases expression |
EXP |
1 |
92,940,318 |
92,952,433 |
RGD:6480464 |
CTD |
| G |
GIF |
gastric intrinsic factor (vitamin B synthesis) |
|
multiple interactions |
EXP |
11 |
59,596,746 |
59,612,974 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
multiple interactions |
EXP |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
multiple interactions |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
increases expression |
EXP |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
increases expression |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
increases expression |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
multiple interactions |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
increases phosphorylation |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
multiple interactions |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
affects localization |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
decreases expression |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
increases phosphorylation |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJB2 |
gap junction protein, beta 2, 26kDa |
|
multiple interactions |
ISO |
13 |
20,761,602 |
20,767,114 |
RGD:6480464 |
CTD |
| G |
GJB2 |
gap junction protein, beta 2, 26kDa |
|
increases expression |
ISO |
13 |
20,761,602 |
20,767,114 |
RGD:6480464 |
CTD |
| G |
GJB2 |
gap junction protein, beta 2, 26kDa |
|
increases expression |
ISO |
13 |
20,761,602 |
20,767,114 |
RGD:6480464 |
CTD |
| G |
GJB2 |
gap junction protein, beta 2, 26kDa |
|
decreases expression |
ISO |
13 |
20,761,602 |
20,767,114 |
RGD:6480464 |
CTD |
| G |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
|
multiple interactions |
ISO |
1 |
35,220,721 |
35,224,112 |
RGD:6480464 |
CTD |
| G |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
|
decreases expression |
ISO |
1 |
35,220,721 |
35,224,112 |
RGD:6480464 |
CTD |
| G |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
|
decreases expression |
ISO |
1 |
35,220,721 |
35,224,112 |
RGD:6480464 |
CTD |
| G |
GNB2L1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
|
multiple interactions |
ISO |
5 |
180,663,928 |
180,670,906 |
RGD:6480464 |
CTD |
| G |
GNRHR |
gonadotropin-releasing hormone receptor |
|
multiple interactions |
EXP |
4 |
68,603,093 |
68,621,804 |
RGD:6480464 |
CTD |
| G |
GPX1 |
glutathione peroxidase 1 |
|
increases expression |
EXP |
3 |
49,394,609 |
49,395,791 |
RGD:6480464 |
CTD |
| G |
GPX4 |
glutathione peroxidase 4 |
|
decreases expression |
EXP |
19 |
1,103,936 |
1,106,787 |
RGD:6480464 |
CTD |
| G |
GRN |
granulin |
|
increases expression |
EXP |
17 |
42,422,491 |
42,430,470 |
RGD:6480464 |
CTD |
| G |
GSK3A |
glycogen synthase kinase 3 alpha |
|
increases phosphorylation |
ISO |
19 |
42,734,338 |
42,746,736 |
RGD:6480464 |
CTD |
| G |
GSK3A |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
ISO |
19 |
42,734,338 |
42,746,736 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases expression |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases activity |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
affects response to substance |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
affects expression |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
affects localization |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
decreases expression |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
GSTT1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
22 |
24,376,139 |
24,384,284 |
RGD:6480464 |
CTD |
| G |
GTF2H4 |
general transcription factor IIH, polypeptide 4, 52kDa |
|
increases expression |
EXP |
6 |
30,875,977 |
30,881,880 |
RGD:6480464 |
CTD |
| G |
GYPA |
glycophorin A (MNS blood group) |
|
increases expression |
EXP |
4 |
145,030,456 |
145,061,904 |
RGD:6480464 |
CTD |
| G |
GYPA |
glycophorin A (MNS blood group) |
|
multiple interactions |
EXP |
4 |
145,030,456 |
145,061,904 |
RGD:6480464 |
CTD |
| G |
HBEGF |
heparin-binding EGF-like growth factor |
|
multiple interactions |
EXP |
5 |
139,712,428 |
139,726,188 |
RGD:6480464 |
CTD |
| G |
HDAC5 |
histone deacetylase 5 |
|
multiple interactions |
ISO |
17 |
42,154,121 |
42,201,014 |
RGD:6480464 |
CTD |
| G |
HDC |
histidine decarboxylase |
|
increases activity |
EXP |
15 |
50,534,144 |
50,558,162 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
|
multiple interactions |
EXP |
4 |
175,411,328 |
175,444,049 |
RGD:6480464 |
CTD |
| G |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
|
increases expression |
EXP |
4 |
175,411,328 |
175,444,049 |
RGD:6480464 |
CTD |
| G |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
|
multiple interactions |
EXP |
4 |
175,411,328 |
175,444,049 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
increases expression |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HRH2 |
histamine receptor H2 |
|
multiple interactions |
ISO |
5 |
175,085,040 |
175,113,245 |
RGD:6480464 |
CTD |
| G |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
increases activity |
ISO |
1 |
209,859,525 |
209,908,295 |
RGD:6480464 |
CTD |
| G |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
increases expression |
ISO |
1 |
209,859,525 |
209,908,295 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions |
ISO |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPB1 |
heat shock 27kDa protein 1 |
|
multiple interactions |
ISO |
7 |
75,931,875 |
75,933,614 |
RGD:6480464 |
CTD |
| G |
HSPB1 |
heat shock 27kDa protein 1 |
|
increases expression |
ISO |
7 |
75,931,875 |
75,933,614 |
RGD:6480464 |
CTD |
| G |
IBSP |
integrin-binding sialoprotein |
|
multiple interactions |
EXP |
4 |
88,720,702 |
88,733,601 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
increases secretion |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGFBP1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
ISO |
7 |
45,927,959 |
45,933,267 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
EXP |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
decreases expression |
EXP |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
increases expression |
EXP |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
increases secretion |
EXP |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression |
EXP |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL12RB1 |
interleukin 12 receptor, beta 1 |
|
increases expression |
EXP |
19 |
18,170,371 |
18,197,697 |
RGD:6480464 |
CTD |
| G |
IL12RB2 |
interleukin 12 receptor, beta 2 |
|
increases expression |
EXP |
1 |
67,773,047 |
67,862,583 |
RGD:6480464 |
CTD |
| G |
IL12RB2 |
interleukin 12 receptor, beta 2 |
|
multiple interactions |
EXP |
1 |
67,773,047 |
67,862,583 |
RGD:6480464 |
CTD |
| G |
IL13 |
interleukin 13 |
|
increases expression |
EXP |
5 |
131,993,865 |
131,996,801 |
RGD:6480464 |
CTD |
| G |
IL18R1 |
interleukin 18 receptor 1 |
|
multiple interactions |
EXP |
2 |
102,979,097 |
103,015,218 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
increases expression |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1RAP |
interleukin 1 receptor accessory protein |
|
multiple interactions |
EXP |
3 |
190,231,840 |
190,374,986 |
RGD:6480464 |
CTD |
| G |
IL1RAPL2 |
interleukin 1 receptor accessory protein-like 2 |
|
multiple interactions |
EXP |
X |
103,810,996 |
105,011,822 |
RGD:6480464 |
CTD |
| G |
IL1RN |
interleukin 1 receptor antagonist |
|
multiple interactions |
EXP |
2 |
113,875,470 |
113,891,593 |
RGD:6480464 |
CTD |
| G |
IL1RN |
interleukin 1 receptor antagonist |
|
increases expression |
EXP |
2 |
113,875,470 |
113,891,593 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
increases expression |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
increases secretion |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
increases expression |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2RA |
interleukin 2 receptor, alpha |
|
multiple interactions |
EXP |
10 |
6,052,657 |
6,104,333 |
RGD:6480464 |
CTD |
| G |
IL2RA |
interleukin 2 receptor, alpha |
|
multiple interactions |
EXP |
10 |
6,052,657 |
6,104,333 |
RGD:6480464 |
CTD |
| G |
IL2RA |
interleukin 2 receptor, alpha |
|
increases expression |
EXP |
10 |
6,052,657 |
6,104,333 |
RGD:6480464 |
CTD |
| G |
IL2RA |
interleukin 2 receptor, alpha |
|
increases secretion |
EXP |
10 |
6,052,657 |
6,104,333 |
RGD:6480464 |
CTD |
| G |
IL2RA |
interleukin 2 receptor, alpha |
|
multiple interactions |
EXP |
10 |
6,052,657 |
6,104,333 |
RGD:6480464 |
CTD |
| G |
IL3 |
interleukin 3 (colony-stimulating factor, multiple) |
|
multiple interactions |
ISO |
5 |
131,396,347 |
131,398,896 |
RGD:6480464 |
CTD |
| G |
IL3 |
interleukin 3 (colony-stimulating factor, multiple) |
|
multiple interactions |
EXP |
5 |
131,396,347 |
131,398,896 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
increases expression |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
EXP |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases secretion |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases expression |
EXP |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5RA |
interleukin 5 receptor, alpha |
|
decreases expression |
EXP |
3 |
3,108,008 |
3,152,058 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6R |
interleukin 6 receptor |
|
multiple interactions |
EXP |
1 |
154,377,669 |
154,441,926 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases secretion |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL9R |
interleukin 9 receptor |
|
multiple interactions |
EXP |
X Y |
155,227,246 59,330,252 |
155,240,482 59,343,488 |
RGD:6480464 |
CTD |
| G |
IRAK3 |
interleukin-1 receptor-associated kinase 3 |
|
multiple interactions |
EXP |
12 |
66,582,978 |
66,648,402 |
RGD:6480464 |
CTD |
| G |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
|
increases expression |
EXP |
5 |
52,285,156 |
52,390,609 |
RGD:6480464 |
CTD |
| G |
ITGA2B |
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
|
increases expression |
EXP |
17 |
42,449,550 |
42,466,873 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
multiple interactions |
EXP |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
increases expression |
EXP |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
increases localization |
EXP |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITGAX |
integrin, alpha X (complement component 3 receptor 4 subunit) |
|
multiple interactions |
EXP |
16 |
31,366,509 |
31,394,318 |
RGD:6480464 |
CTD |
| G |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
|
multiple interactions |
EXP |
17 |
45,331,208 |
45,390,077 |
RGD:6480464 |
CTD |
| G |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
|
increases expression |
EXP |
17 |
45,331,208 |
45,390,077 |
RGD:6480464 |
CTD |
| G |
ITGB6 |
integrin, beta 6 |
|
multiple interactions |
EXP |
2 |
160,958,233 |
161,056,590 |
RGD:6480464 |
CTD |
| G |
IVL |
involucrin |
|
multiple interactions |
EXP |
1 |
152,881,039 |
152,884,362 |
RGD:6480464 |
CTD |
| G |
IVL |
involucrin |
|
increases expression |
EXP |
1 |
152,881,039 |
152,884,362 |
RGD:6480464 |
CTD |
| G |
IVL |
involucrin |
|
increases expression |
ISO |
1 |
152,881,039 |
152,884,362 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases activity |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases activity |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
multiple interactions |
EXP |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
multiple interactions |
EXP |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
JUND |
jun D proto-oncogene |
|
multiple interactions |
EXP |
19 |
18,390,563 |
18,392,432 |
RGD:6480464 |
CTD |
| G |
JUND |
jun D proto-oncogene |
|
increases expression |
EXP |
19 |
18,390,563 |
18,392,432 |
RGD:6480464 |
CTD |
| G |
JUND |
jun D proto-oncogene |
|
multiple interactions |
EXP |
19 |
18,390,563 |
18,392,432 |
RGD:6480464 |
CTD |
| G |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
|
decreases activity |
EXP |
1 |
112,318,454 |
112,531,777 |
RGD:6480464 |
CTD |
| G |
KCNE1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
decreases activity |
ISO |
21 |
35,818,986 |
35,884,573 |
RGD:6480464 |
CTD |
| G |
KCNIP2 |
Kv channel interacting protein 2 |
|
decreases expression |
ISO |
10 |
103,585,731 |
103,603,677 |
RGD:6480464 |
CTD |
| G |
KCNIP2 |
Kv channel interacting protein 2 |
|
multiple interactions |
ISO |
10 |
103,585,731 |
103,603,677 |
RGD:6480464 |
CTD |
| G |
KCNJ4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
multiple interactions |
ISO |
22 |
38,822,332 |
38,851,205 |
RGD:6480464 |
CTD |
| G |
KIF20A |
kinesin family member 20A |
|
multiple interactions |
EXP |
5 |
137,514,417 |
137,523,404 |
RGD:6480464 |
CTD |
| G |
KIF20B |
kinesin family member 20B |
|
increases expression |
EXP |
10 |
91,461,367 |
91,534,700 |
RGD:6480464 |
CTD |
| G |
KIF23 |
kinesin family member 23 |
|
increases expression |
EXP |
15 |
69,706,627 |
69,740,764 |
RGD:6480464 |
CTD |
| G |
KIF2C |
kinesin family member 2C |
|
increases expression |
EXP |
1 |
45,205,490 |
45,233,439 |
RGD:6480464 |
CTD |
| G |
KLF12 |
Kruppel-like factor 12 |
|
multiple interactions |
EXP |
13 |
74,260,149 |
74,708,066 |
RGD:6480464 |
CTD |
| G |
KPNB1 |
karyopherin (importin) beta 1 |
|
increases expression |
ISO |
17 |
45,727,275 |
45,761,004 |
RGD:6480464 |
CTD |
| G |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
12 |
25,358,180 |
25,403,854 |
RGD:6480464 |
CTD |
| G |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
12 |
25,358,180 |
25,403,854 |
RGD:6480464 |
CTD |
| G |
KRT18 |
keratin 18 |
|
multiple interactions |
ISO |
12 |
53,342,655 |
53,346,685 |
RGD:6480464 |
CTD |
| G |
KRT8 |
keratin 8 |
|
multiple interactions |
ISO |
12 |
53,290,971 |
53,343,650 |
RGD:6480464 |
CTD |
| G |
LAMB1 |
laminin, beta 1 |
|
multiple interactions |
EXP |
7 |
107,564,246 |
107,643,804 |
RGD:6480464 |
CTD |
| G |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
|
multiple interactions |
EXP |
13 |
46,700,058 |
46,756,459 |
RGD:6480464 |
CTD |
| G |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
|
increases phosphorylation |
EXP |
13 |
46,700,058 |
46,756,459 |
RGD:6480464 |
CTD |
| G |
LIF |
leukemia inhibitory factor |
|
multiple interactions |
EXP |
22 |
30,636,436 |
30,642,840 |
RGD:6480464 |
CTD |
| G |
LMO7 |
LIM domain 7 |
|
multiple interactions |
EXP |
13 |
76,194,570 |
76,434,006 |
RGD:6480464 |
CTD |
| G |
LPL |
lipoprotein lipase |
|
increases expression |
EXP |
8 |
19,796,582 |
19,824,770 |
RGD:6480464 |
CTD |
| G |
LRP1 |
low density lipoprotein receptor-related protein 1 |
|
increases expression |
EXP |
12 |
57,522,282 |
57,607,142 |
RGD:6480464 |
CTD |
| G |
LRP1 |
low density lipoprotein receptor-related protein 1 |
|
multiple interactions |
EXP |
12 |
57,522,282 |
57,607,142 |
RGD:6480464 |
CTD |
| G |
MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
|
increases expression |
EXP |
7 |
1,855,428 |
2,272,583 |
RGD:6480464 |
CTD |
| G |
MAD2L1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
|
increases expression |
EXP |
4 |
120,980,577 |
120,988,013 |
RGD:6480464 |
CTD |
| G |
MAP1LC3B |
microtubule-associated protein 1 light chain 3 beta |
|
multiple interactions |
EXP |
16 |
87,425,801 |
87,438,380 |
RGD:6480464 |
CTD |
| G |
MAP1LC3B |
microtubule-associated protein 1 light chain 3 beta |
|
increases expression |
EXP |
16 |
87,425,801 |
87,438,380 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
increases phosphorylation |
EXP |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
increases activity |
ISO |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
EXP |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
increases phosphorylation |
EXP |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
|
multiple interactions |
ISO |
17 |
11,924,135 |
12,047,051 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases activity |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases expression |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
increases activity |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
increases phosphorylation |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
ISO |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases activity |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases expression |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8IP1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
multiple interactions |
ISO |
11 |
45,907,047 |
45,928,016 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
|
increases phosphorylation |
ISO |
6 |
114,178,527 |
114,184,652 |
RGD:6480464 |
CTD |
| G |
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
|
multiple interactions |
EXP |
10 |
54,525,140 |
54,531,460 |
RGD:6480464 |
CTD |
| G |
MEOX2 |
mesenchyme homeobox 2 |
|
multiple interactions |
EXP |
7 |
15,650,837 |
15,726,308 |
RGD:6480464 |
CTD |
| G |
MERTK |
c-mer proto-oncogene tyrosine kinase |
|
increases cleavage |
EXP |
2 |
112,656,191 |
112,786,945 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MME |
membrane metallo-endopeptidase |
|
decreases expression |
EXP |
3 |
154,797,436 |
154,901,518 |
RGD:6480464 |
CTD |
| G |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
EXP |
11 |
102,660,641 |
102,668,966 |
RGD:6480464 |
CTD |
| G |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
EXP |
11 |
102,660,641 |
102,668,966 |
RGD:6480464 |
CTD |
| G |
MMP21 |
matrix metallopeptidase 21 |
|
increases expression |
EXP |
10 |
127,455,022 |
127,464,390 |
RGD:6480464 |
CTD |
| G |
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
|
increases expression |
EXP |
11 |
102,706,528 |
102,714,342 |
RGD:6480464 |
CTD |
| G |
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
|
multiple interactions |
EXP |
11 |
102,706,528 |
102,714,342 |
RGD:6480464 |
CTD |
| G |
MMP8 |
matrix metallopeptidase 8 (neutrophil collagenase) |
|
multiple interactions |
EXP |
11 |
102,582,526 |
102,595,685 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
EXP |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
EXP |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
increases activity |
EXP |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
increases activity |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MSLN |
mesothelin |
|
multiple interactions |
EXP |
16 |
810,765 |
818,865 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
multiple interactions |
EXP |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
multiple interactions |
EXP |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
increases expression |
EXP |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
increases expression |
EXP |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
increases expression |
ISO |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MSR1 |
macrophage scavenger receptor 1 |
|
multiple interactions |
ISO |
8 |
15,965,387 |
16,050,300 |
RGD:6480464 |
CTD |
| G |
MUC1 |
mucin 1, cell surface associated |
|
multiple interactions |
EXP |
1 |
155,158,300 |
155,162,706 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases expression |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYL9 |
myosin, light chain 9, regulatory |
|
multiple interactions |
ISO |
20 |
35,169,887 |
35,178,226 |
RGD:6480464 |
CTD |
| G |
MYL9 |
myosin, light chain 9, regulatory |
|
increases phosphorylation |
ISO |
20 |
35,169,887 |
35,178,226 |
RGD:6480464 |
CTD |
| G |
MZF1 |
myeloid zinc finger 1 |
|
multiple interactions |
EXP |
19 |
59,073,284 |
59,084,942 |
RGD:6480464 |
CTD |
| G |
NAP1L3 |
nucleosome assembly protein 1-like 3 |
|
multiple interactions |
EXP |
X |
92,925,925 |
92,928,682 |
RGD:6480464 |
CTD |
| G |
NCAPG |
non-SMC condensin I complex, subunit G |
|
increases expression |
EXP |
4 |
17,812,436 |
17,846,488 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
multiple interactions |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
multiple interactions |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
multiple interactions |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
affects localization |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
increases expression |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
increases phosphorylation |
EXP |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
EXP |
1 |
183,524,697 |
183,560,056 |
RGD:6480464 |
CTD |
| G |
NCF2 |
neutrophil cytosolic factor 2 |
|
affects localization |
EXP |
1 |
183,524,697 |
183,560,056 |
RGD:6480464 |
CTD |
| G |
NEK2 |
NIMA-related kinase 2 |
|
increases expression |
EXP |
1 |
211,831,598 |
211,848,972 |
RGD:6480464 |
CTD |
| G |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
multiple interactions |
ISO |
16 |
68,119,269 |
68,263,162 |
RGD:6480464 |
CTD |
| G |
NFIB |
nuclear factor I/B |
|
multiple interactions |
EXP |
9 |
14,081,842 |
14,398,982 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects localization |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
ISO |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIL1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
|
multiple interactions |
EXP |
6 |
31,514,628 |
31,526,606 |
RGD:6480464 |
CTD |
| G |
NOLC1 |
nucleolar and coiled-body phosphoprotein 1 |
|
increases expression |
EXP |
10 |
103,911,933 |
103,923,627 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NPHS1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
decreases expression |
ISO |
19 |
36,316,274 |
36,342,895 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
multiple interactions |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
increases expression |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
multiple interactions |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPY |
neuropeptide Y |
|
multiple interactions |
ISO |
7 |
24,323,807 |
24,331,484 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
EXP |
6 |
3,000,067 |
3,019,994 |
RGD:6480464 |
CTD |
| G |
NR1I2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
3 |
119,499,331 |
119,537,332 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
ISO |
4 |
148,999,915 |
149,363,672 |
RGD:6480464 |
CTD |
| G |
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
|
affects localization |
EXP |
12 |
52,416,616 |
52,453,291 |
RGD:6480464 |
CTD |
| G |
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
EXP |
12 |
52,416,616 |
52,453,291 |
RGD:6480464 |
CTD |
| G |
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
12 |
52,416,616 |
52,453,291 |
RGD:6480464 |
CTD |
| G |
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
|
multiple interactions |
EXP |
2 |
157,180,944 |
157,189,287 |
RGD:6480464 |
CTD |
| G |
NR4A3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
EXP |
9 |
102,584,137 |
102,629,173 |
RGD:6480464 |
CTD |
| G |
NR5A2 |
nuclear receptor subfamily 5, group A, member 2 |
|
multiple interactions |
EXP |
1 |
199,996,770 |
200,146,552 |
RGD:6480464 |
CTD |
| G |
NUSAP1 |
nucleolar and spindle associated protein 1 |
|
increases expression |
EXP |
15 |
41,624,892 |
41,673,248 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases activity |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
multiple interactions |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
multiple interactions |
EXP |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
multiple interactions |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
OPRM1 |
opioid receptor, mu 1 |
|
increases expression |
EXP |
6 |
154,331,631 |
154,568,001 |
RGD:6480464 |
CTD |
| G |
OPRM1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
6 |
154,331,631 |
154,568,001 |
RGD:6480464 |
CTD |
| G |
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
ISO |
11 |
72,929,344 |
72,947,397 |
RGD:6480464 |
CTD |
| G |
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3 |
|
increases expression |
EXP |
X |
110,187,513 |
110,464,173 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases activity |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP2 |
poly (ADP-ribose) polymerase 2 |
|
increases expression |
EXP |
14 |
20,811,773 |
20,826,063 |
RGD:6480464 |
CTD |
| G |
PBK |
PDZ binding kinase |
|
increases expression |
EXP |
8 |
27,667,138 |
27,695,349 |
RGD:6480464 |
CTD |
| G |
PCDHA2 |
protocadherin alpha 2 |
|
multiple interactions |
EXP |
5 |
140,174,444 |
140,391,929 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCOLCE |
procollagen C-endopeptidase enhancer |
|
multiple interactions |
EXP |
7 |
100,199,882 |
100,205,798 |
RGD:6480464 |
CTD |
| G |
PDGFA |
platelet-derived growth factor alpha polypeptide |
|
increases expression |
EXP |
7 |
536,895 |
559,481 |
RGD:6480464 |
CTD |
| G |
PDGFA |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
EXP |
7 |
536,895 |
559,481 |
RGD:6480464 |
CTD |
| G |
PDGFB |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
EXP |
22 |
39,619,685 |
39,640,957 |
RGD:6480464 |
CTD |
| G |
PDGFB |
platelet-derived growth factor beta polypeptide |
|
increases expression |
EXP |
22 |
39,619,685 |
39,640,957 |
RGD:6480464 |
CTD |
| G |
PIN1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
multiple interactions |
EXP |
19 |
9,945,883 |
9,960,365 |
RGD:6480464 |
CTD |
| G |
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
EXP |
1 |
20,301,924 |
20,306,932 |
RGD:6480464 |
CTD |
| G |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases phosphorylation |
ISO |
1 |
186,798,032 |
186,958,113 |
RGD:6480464 |
CTD |
| G |
PLCB2 |
phospholipase C, beta 2 |
|
affects localization |
EXP |
15 |
40,580,098 |
40,600,174 |
RGD:6480464 |
CTD |
| G |
PLCB2 |
phospholipase C, beta 2 |
|
multiple interactions |
EXP |
15 |
40,580,098 |
40,600,174 |
RGD:6480464 |
CTD |
| G |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
|
increases activity |
ISO |
3 |
171,318,195 |
171,528,284 |
RGD:6480464 |
CTD |
| G |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
|
multiple interactions |
ISO |
3 |
171,318,195 |
171,528,284 |
RGD:6480464 |
CTD |
| G |
PLD2 |
phospholipase D2 |
|
multiple interactions |
EXP |
17 |
4,710,396 |
4,726,727 |
RGD:6480464 |
CTD |
| G |
PLD2 |
phospholipase D2 |
|
multiple interactions |
ISO |
17 |
4,710,396 |
4,726,727 |
RGD:6480464 |
CTD |
| G |
PLD2 |
phospholipase D2 |
|
increases activity |
ISO |
17 |
4,710,396 |
4,726,727 |
RGD:6480464 |
CTD |
| G |
PLK1 |
polo-like kinase 1 |
|
increases expression |
EXP |
16 |
23,690,201 |
23,701,688 |
RGD:6480464 |
CTD |
| G |
POLE2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
increases expression |
EXP |
14 |
50,110,270 |
50,155,098 |
RGD:6480464 |
CTD |
| G |
POU2F1 |
POU class 2 homeobox 1 |
|
multiple interactions |
EXP |
1 |
167,190,066 |
167,396,582 |
RGD:6480464 |
CTD |
| G |
POU4F3 |
POU class 4 homeobox 3 |
|
multiple interactions |
EXP |
5 |
145,718,587 |
145,720,083 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
multiple interactions |
EXP |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
increases activity |
ISO |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARD |
peroxisome proliferator-activated receptor delta |
|
multiple interactions |
ISO |
6 |
35,310,335 |
35,395,968 |
RGD:6480464 |
CTD |
| G |
PPARD |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
6 |
35,310,335 |
35,395,968 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPBP |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
increases expression |
EXP |
4 |
74,852,156 |
74,853,907 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
affects localization |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
decreases expression |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
decreases phosphorylation |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
affects localization |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
increases expression |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
increases localization |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
affects localization |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCB |
protein kinase C, beta |
|
affects localization |
EXP |
16 |
23,847,300 |
24,231,932 |
RGD:6480464 |
CTD |
| G |
PRKCB |
protein kinase C, beta |
|
multiple interactions |
EXP |
16 |
23,847,300 |
24,231,932 |
RGD:6480464 |
CTD |
| G |
PRKCB |
protein kinase C, beta |
|
multiple interactions |
EXP |
16 |
23,847,300 |
24,231,932 |
RGD:6480464 |
CTD |
| G |
PRKCB |
protein kinase C, beta |
|
decreases phosphorylation |
EXP |
16 |
23,847,300 |
24,231,932 |
RGD:6480464 |
CTD |
| G |
PRKCB |
protein kinase C, beta |
|
increases activity |
ISO |
16 |
23,847,300 |
24,231,932 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
affects localization |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
decreases expression |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
affects phosphorylation |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
increases phosphorylation |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
increases activity |
ISO |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
increases localization |
ISO |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
ISO |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
ISO |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
affects localization |
ISO |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
affects localization |
EXP |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
increases activity |
EXP |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
affects localization |
ISO |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKCG |
protein kinase C, gamma |
|
decreases expression |
EXP |
19 |
54,385,467 |
54,410,901 |
RGD:6480464 |
CTD |
| G |
PRKCG |
protein kinase C, gamma |
|
increases activity |
EXP |
19 |
54,385,467 |
54,410,901 |
RGD:6480464 |
CTD |
| G |
PRKCG |
protein kinase C, gamma |
|
affects localization |
ISO |
19 |
54,385,467 |
54,410,901 |
RGD:6480464 |
CTD |
| G |
PRKCH |
protein kinase C, eta |
|
increases activity |
EXP |
14 |
61,788,515 |
62,017,698 |
RGD:6480464 |
CTD |
| G |
PRKCH |
protein kinase C, eta |
|
multiple interactions |
EXP |
14 |
61,788,515 |
62,017,698 |
RGD:6480464 |
CTD |
| G |
PRKCQ |
protein kinase C, theta |
|
multiple interactions |
EXP |
10 |
6,469,105 |
6,622,254 |
RGD:6480464 |
CTD |
| G |
PRKCZ |
protein kinase C, zeta |
|
affects localization |
EXP |
1 |
1,981,909 |
2,116,834 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
multiple interactions |
EXP |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
affects phosphorylation |
EXP |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
multiple interactions |
ISO |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
affects localization |
ISO |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PSMC2 |
proteasome (prosome, macropain) 26S subunit, ATPase, 2 |
|
increases expression |
ISO |
7 |
102,987,971 |
103,009,842 |
RGD:6480464 |
CTD |
| G |
PSMC6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
increases expression |
ISO |
14 |
53,173,896 |
53,194,716 |
RGD:6480464 |
CTD |
| G |
PTAFR |
platelet-activating factor receptor |
|
multiple interactions |
ISO |
1 |
28,473,677 |
28,520,447 |
RGD:6480464 |
CTD |
| G |
PTAFR |
platelet-activating factor receptor |
|
increases phosphorylation |
ISO |
1 |
28,473,677 |
28,520,447 |
RGD:6480464 |
CTD |
| G |
PTGES |
prostaglandin E synthase |
|
multiple interactions |
EXP |
9 |
132,500,615 |
132,515,344 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTK2B |
protein tyrosine kinase 2 beta |
|
multiple interactions |
ISO |
8 |
27,168,999 |
27,316,908 |
RGD:6480464 |
CTD |
| G |
PTPRN2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
|
multiple interactions |
EXP |
7 |
157,331,750 |
158,380,482 |
RGD:6480464 |
CTD |
| G |
PTTG1 |
pituitary tumor-transforming 1 |
|
increases expression |
EXP |
5 |
159,848,865 |
159,855,746 |
RGD:6480464 |
CTD |
| G |
PTX3 |
pentraxin 3, long |
|
multiple interactions |
EXP |
3 |
157,154,580 |
157,161,417 |
RGD:6480464 |
CTD |
| G |
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
multiple interactions |
EXP |
7 |
6,414,126 |
6,443,598 |
RGD:6480464 |
CTD |
| G |
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
increases expression |
EXP |
7 |
6,414,126 |
6,443,598 |
RGD:6480464 |
CTD |
| G |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
multiple interactions |
ISO |
22 |
37,621,310 |
37,640,305 |
RGD:6480464 |
CTD |
| G |
RAD51AP1 |
RAD51 associated protein 1 |
|
increases expression |
EXP |
12 |
4,647,950 |
4,669,213 |
RGD:6480464 |
CTD |
| G |
RAD51C |
RAD51 homolog C (S. cerevisiae) |
|
increases expression |
EXP |
17 |
56,769,963 |
56,811,692 |
RGD:6480464 |
CTD |
| G |
RAD54L |
RAD54-like (S. cerevisiae) |
|
multiple interactions |
EXP |
1 |
46,713,367 |
46,744,145 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
multiple interactions |
ISO |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
multiple interactions |
ISO |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
increases activity |
ISO |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
increases expression |
ISO |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RARA |
retinoic acid receptor, alpha |
|
multiple interactions |
EXP |
17 |
38,465,423 |
38,513,895 |
RGD:6480464 |
CTD |
| G |
RARRES1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
multiple interactions |
EXP |
3 |
158,414,897 |
158,450,275 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
decreases phosphorylation |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
increases expression |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
increases phosphorylation |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RBBP8 |
retinoblastoma binding protein 8 |
|
increases expression |
EXP |
18 |
20,513,295 |
20,606,449 |
RGD:6480464 |
CTD |
| G |
RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
22 |
41,347,351 |
41,369,019 |
RGD:6480464 |
CTD |
| G |
REL |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
2 |
61,108,752 |
61,150,178 |
RGD:6480464 |
CTD |
| G |
REL |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
affects localization |
EXP |
2 |
61,108,752 |
61,150,178 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases phosphorylation |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RFC4 |
replication factor C (activator 1) 4, 37kDa |
|
increases expression |
EXP |
3 |
186,507,681 |
186,524,484 |
RGD:6480464 |
CTD |
| G |
RFC5 |
replication factor C (activator 1) 5, 36.5kDa |
|
increases expression |
EXP |
12 |
118,454,506 |
118,470,044 |
RGD:6480464 |
CTD |
| G |
RGCC |
regulator of cell cycle |
|
multiple interactions |
EXP |
13 |
42,031,542 |
42,045,013 |
RGD:6480464 |
CTD |
| G |
RGS11 |
regulator of G-protein signaling 11 |
|
multiple interactions |
EXP |
16 |
318,310 |
325,914 |
RGD:6480464 |
CTD |
| G |
RGS13 |
regulator of G-protein signaling 13 |
|
multiple interactions |
EXP |
1 |
192,605,268 |
192,629,441 |
RGD:6480464 |
CTD |
| G |
RGS4 |
regulator of G-protein signaling 4 |
|
multiple interactions |
ISO |
1 |
163,038,396 |
163,046,592 |
RGD:6480464 |
CTD |
| G |
RNF4 |
ring finger protein 4 |
|
multiple interactions |
ISO |
4 |
2,470,795 |
2,517,586 |
RGD:6480464 |
CTD |
| G |
RPS6 |
ribosomal protein S6 |
|
multiple interactions |
EXP |
9 |
19,376,254 |
19,380,235 |
RGD:6480464 |
CTD |
| G |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
increases phosphorylation |
ISO |
1 |
26,856,249 |
26,901,520 |
RGD:6480464 |
CTD |
| G |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
26,856,249 |
26,901,520 |
RGD:6480464 |
CTD |
| G |
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
multiple interactions |
ISO |
17 |
57,970,443 |
58,027,787 |
RGD:6480464 |
CTD |
| G |
RXRA |
retinoid X receptor, alpha |
|
decreases degradation |
EXP |
9 |
137,218,316 |
137,332,431 |
RGD:6480464 |
CTD |
| G |
RXRA |
retinoid X receptor, alpha |
|
multiple interactions |
EXP |
9 |
137,218,316 |
137,332,431 |
RGD:6480464 |
CTD |
| G |
RXRA |
retinoid X receptor, alpha |
|
decreases localization |
EXP |
9 |
137,218,316 |
137,332,431 |
RGD:6480464 |
CTD |
| G |
S100A8 |
S100 calcium binding protein A8 |
|
increases expression |
EXP |
1 |
153,362,508 |
153,363,664 |
RGD:6480464 |
CTD |
| G |
S100A9 |
S100 calcium binding protein A9 |
|
increases expression |
EXP |
1 |
153,330,330 |
153,333,503 |
RGD:6480464 |
CTD |
| G |
S100P |
S100 calcium binding protein P |
|
multiple interactions |
EXP |
4 |
6,695,566 |
6,698,897 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
multiple interactions |
EXP |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
increases expression |
EXP |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
affects expression |
ISO |
18 |
61,554,939 |
61,571,124 |
RGD:6480464 |
CTD |
| G |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
affects response to substance |
ISO |
18 |
61,554,939 |
61,571,124 |
RGD:6480464 |
CTD |
| G |
SERPINB9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
increases expression |
EXP |
6 |
2,887,499 |
2,903,546 |
RGD:6480464 |
CTD |
| G |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
7 |
100,770,370 |
100,782,547 |
RGD:6480464 |
CTD |
| G |
SFTPB |
surfactant protein B |
|
increases secretion |
ISO |
2 |
85,884,440 |
85,895,864 |
RGD:6480464 |
CTD |
| G |
SFTPB |
surfactant protein B |
|
increases secretion |
ISO |
2 |
85,884,440 |
85,895,864 |
RGD:6480464 |
CTD |
| G |
SFTPB |
surfactant protein B |
|
multiple interactions |
ISO |
2 |
85,884,440 |
85,895,864 |
RGD:6480464 |
CTD |
| G |
SFTPC |
surfactant protein C |
|
increases secretion |
ISO |
8 |
22,019,184 |
22,021,992 |
RGD:6480464 |
CTD |
| G |
SFTPC |
surfactant protein C |
|
multiple interactions |
ISO |
8 |
22,019,184 |
22,021,992 |
RGD:6480464 |
CTD |
| G |
SFTPC |
surfactant protein C |
|
increases secretion |
ISO |
8 |
22,019,184 |
22,021,992 |
RGD:6480464 |
CTD |
| G |
SFTPD |
surfactant protein D |
|
multiple interactions |
ISO |
10 |
81,697,496 |
81,708,861 |
RGD:6480464 |
CTD |
| G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
6 |
134,490,384 |
134,639,196 |
RGD:6480464 |
CTD |
| G |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
|
multiple interactions |
EXP |
11 |
70,313,961 |
70,935,808 |
RGD:6480464 |
CTD |
| G |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases activity |
ISO |
9 |
4,490,427 |
4,587,469 |
RGD:6480464 |
CTD |
| G |
SLC5A6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
|
multiple interactions |
EXP |
2 |
27,422,455 |
27,435,175 |
RGD:6480464 |
CTD |
| G |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
EXP |
4 |
139,085,248 |
139,163,503 |
RGD:6480464 |
CTD |
| G |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
4 |
139,085,248 |
139,163,503 |
RGD:6480464 |
CTD |
| G |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
ISO |
2 |
40,339,286 |
40,739,575 |
RGD:6480464 |
CTD |
| G |
SMC4 |
structural maintenance of chromosomes 4 |
|
increases expression |
EXP |
3 |
160,117,430 |
160,152,741 |
RGD:6480464 |
CTD |
| G |
SOCS2 |
suppressor of cytokine signaling 2 |
|
multiple interactions |
EXP |
12 |
93,963,598 |
93,970,521 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
multiple interactions |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
increases activity |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SPAG5 |
sperm associated antigen 5 |
|
increases expression |
EXP |
17 |
26,904,583 |
26,926,056 |
RGD:6480464 |
CTD |
| G |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene spi1 |
|
increases activity |
EXP |
11 |
47,376,409 |
47,400,127 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPRR1A |
small proline-rich protein 1A |
|
increases expression |
EXP |
1 |
152,956,564 |
152,958,290 |
RGD:6480464 |
CTD |
| G |
SPRR1A |
small proline-rich protein 1A |
|
increases expression |
ISO |
1 |
152,956,564 |
152,958,290 |
RGD:6480464 |
CTD |
| G |
SPRR1A |
small proline-rich protein 1A |
|
increases expression |
ISO |
1 |
152,956,564 |
152,958,290 |
RGD:6480464 |
CTD |
| G |
SPRR1B |
small proline-rich protein 1B |
|
increases expression |
EXP |
1 |
153,003,679 |
153,005,376 |
RGD:6480464 |
CTD |
| G |
SPRR2A |
small proline-rich protein 2A |
|
multiple interactions |
EXP |
1 |
153,028,596 |
153,029,988 |
RGD:6480464 |
CTD |
| G |
SYNCRIP |
synaptotagmin binding, cytoplasmic RNA interacting protein |
|
multiple interactions |
EXP |
6 |
86,317,502 |
86,353,043 |
RGD:6480464 |
CTD |
| G |
SYNCRIP |
synaptotagmin binding, cytoplasmic RNA interacting protein |
|
affects localization |
EXP |
6 |
86,317,502 |
86,353,043 |
RGD:6480464 |
CTD |
| G |
TAF15 |
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa |
|
multiple interactions |
EXP |
17 |
34,136,459 |
34,174,246 |
RGD:6480464 |
CTD |
| G |
TAGLN |
transgelin |
|
decreases expression |
EXP |
11 |
117,070,040 |
117,075,508 |
RGD:6480464 |
CTD |
| G |
TFRC |
transferrin receptor (p90, CD71) |
|
multiple interactions |
EXP |
3 |
195,776,155 |
195,809,032 |
RGD:6480464 |
CTD |
| G |
TFRC |
transferrin receptor (p90, CD71) |
|
increases expression |
EXP |
3 |
195,776,155 |
195,809,032 |
RGD:6480464 |
CTD |
| G |
TGFA |
transforming growth factor, alpha |
|
multiple interactions |
ISO |
2 |
70,674,412 |
70,781,147 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB2 |
transforming growth factor, beta 2 |
|
multiple interactions |
EXP |
1 |
218,518,676 |
218,617,961 |
RGD:6480464 |
CTD |
| G |
TGM1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
increases expression |
EXP |
14 |
24,718,320 |
24,732,416 |
RGD:6480464 |
CTD |
| G |
TGM1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
increases expression |
ISO |
14 |
24,718,320 |
24,732,416 |
RGD:6480464 |
CTD |
| G |
THPO |
thrombopoietin |
|
multiple interactions |
EXP |
3 |
184,089,773 |
184,095,932 |
RGD:6480464 |
CTD |
| G |
TIMM17A |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
multiple interactions |
EXP |
1 |
201,924,619 |
201,939,789 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TLR6 |
toll-like receptor 6 |
|
multiple interactions |
EXP |
4 |
38,825,325 |
38,858,438 |
RGD:6480464 |
CTD |
| G |
TNC |
tenascin C |
|
multiple interactions |
EXP |
9 |
117,781,854 |
117,880,536 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
multiple interactions |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
decreases expression |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
increases expression |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
|
multiple interactions |
EXP |
1 |
12,227,060 |
12,269,277 |
RGD:6480464 |
CTD |
| G |
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
|
increases expression |
EXP |
1 |
12,227,060 |
12,269,277 |
RGD:6480464 |
CTD |
| G |
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
|
multiple interactions |
EXP |
1 |
7,975,931 |
8,003,225 |
RGD:6480464 |
CTD |
| G |
TNFSF11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
13 |
43,136,872 |
43,182,149 |
RGD:6480464 |
CTD |
| G |
TNNI3 |
troponin I type 3 (cardiac) |
|
multiple interactions |
ISO |
19 |
55,663,135 |
55,669,100 |
RGD:6480464 |
CTD |
| G |
TNNT2 |
troponin T type 2 (cardiac) |
|
multiple interactions |
ISO |
1 |
201,328,142 |
201,346,805 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TPX2 |
TPX2, microtubule-associated, homolog (Xenopus laevis) |
|
increases expression |
EXP |
20 |
30,326,904 |
30,389,603 |
RGD:6480464 |
CTD |
| G |
TRGC2 |
T cell receptor gamma constant 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
|
multiple interactions |
EXP |
12 |
72,666,529 |
73,059,422 |
RGD:6480464 |
CTD |
| G |
TRPC3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
increases expression |
ISO |
4 |
122,800,183 |
122,872,909 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TSC2 |
tuberous sclerosis 2 |
|
increases phosphorylation |
ISO |
16 |
2,097,990 |
2,138,713 |
RGD:6480464 |
CTD |
| G |
TSC2 |
tuberous sclerosis 2 |
|
multiple interactions |
ISO |
16 |
2,097,990 |
2,138,713 |
RGD:6480464 |
CTD |
| G |
TXNRD1 |
thioredoxin reductase 1 |
|
increases expression |
EXP |
12 |
104,609,557 |
104,744,085 |
RGD:6480464 |
CTD |
| G |
TYMP |
thymidine phosphorylase |
|
multiple interactions |
EXP |
22 |
50,964,181 |
50,968,514 |
RGD:6480464 |
CTD |
| G |
TYMP |
thymidine phosphorylase |
|
increases activity |
EXP |
22 |
50,964,181 |
50,968,514 |
RGD:6480464 |
CTD |
| G |
TYMP |
thymidine phosphorylase |
|
increases expression |
EXP |
22 |
50,964,181 |
50,968,514 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
increases expression |
EXP |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
UHRF1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
decreases expression |
EXP |
19 |
4,909,510 |
4,962,165 |
RGD:6480464 |
CTD |
| G |
VIMP |
VCP-interacting membrane protein |
|
multiple interactions |
ISO |
15 |
101,811,214 |
101,817,700 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
increases activity |
ISO |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
multiple interactions |
ISO |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
ZEB1 |
zinc finger E-box binding homeobox 1 |
|
multiple interactions |
EXP |
10 |
31,608,101 |
31,818,742 |
RGD:6480464 |
CTD |
| G |
ZEB1 |
zinc finger E-box binding homeobox 1 |
|
multiple interactions |
ISO |
10 |
31,608,101 |
31,818,742 |
RGD:6480464 |
CTD |
| G |
ZEB2 |
zinc finger E-box binding homeobox 2 |
|
multiple interactions |
EXP |
2 |
145,141,942 |
145,277,958 |
RGD:6480464 |
CTD |
| G |
ZNF235 |
zinc finger protein 235 |
|
multiple interactions |
EXP |
19 |
44,790,501 |
44,809,178 |
RGD:6480464 |
CTD |
| G |
ZNF257 |
zinc finger protein 257 |
|
multiple interactions |
EXP |
19 |
22,235,266 |
22,273,905 |
RGD:6480464 |
CTD |
| G |
ZWINT |
ZW10 interactor, kinetochore protein |
|
increases expression |
EXP |
10 |
58,117,199 |
58,121,034 |
RGD:6480464 |
CTD |
Term paths to the root
|